Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
France
Biotech
Ipsen inks €1B buyout of French biotech ImCheck
Ipsen is acquiring next-gen immuno-oncology biotech ImCheck for its investigational cancer combo therapy in a deal worth up $1.16 billion.
Gabrielle Masson
Oct 22, 2025 10:33am
French antibody biotech draws in $122M for push to clinic
Oct 16, 2025 11:19am
OSE to lead mRNA project with €1.3M from French government
May 21, 2025 4:26pm
Sofinnova closes €165M European biotech acceleration fund
Mar 18, 2025 4:01am
Stryker to snag French joint replacement maker Serf SAS
Dec 18, 2023 11:07am
Medtronic stamps healthcare data collab with France's La Poste
Oct 30, 2023 12:35pm